aurintricarboxylic acid has been researched along with rifampin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lowery, C; Richardson, JP | 1 |
| Burkley, M; Dinda, S; Hurd, C; Kodali-Gali, S; Moudgil, VK; Sevilla, L | 1 |
2 other study(ies) available for aurintricarboxylic acid and rifampin
| Article | Year |
|---|---|
Characterization of the nucleoside triphosphate phosphohydrolase (ATPase) activity of RNA synthesi termination factor p. I. Enzymatic properties and effects of inhibitors.
Topics: Adenosine Triphosphatases; Aurintricarboxylic Acid; Bacterial Proteins; Cations, Divalent; DNA-Directed RNA Polymerases; Edetic Acid; Egtazic Acid; Enzyme Activation; Escherichia coli; Fusidic Acid; Heparin; Kinetics; Magnesium; Phenanthrolines; Rifampin; RNA, Bacterial; Transcription, Genetic | 1977 |
Inhibition of proliferation of T47D human breast cancer cells: alterations in progesterone receptor and p53 tumor suppressor protein.
Topics: Antineoplastic Agents; Aurintricarboxylic Acid; Blotting, Western; Breast Neoplasms; Cell Division; DNA-Binding Proteins; Down-Regulation; Drug Screening Assays, Antitumor; Electrophoresis, Polyacrylamide Gel; Humans; Neoplasms, Hormone-Dependent; Phenanthrolines; Progesterone Congeners; Promegestone; Receptors, Progesterone; Rifampin; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1997 |